HR 6807 118th Congress House Health Appropriations Cancer Congressional oversight Drug therapy Government studies and investigations Medical research Prescription drugs Research administration and funding

KO Cancer Act

Introduced: December 3, 2024 Introduced by: Fitzpatrick, Brian K. Republican · Pennsylvania See on congress.gov

Everywhere this bill has been 3 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Dec 15, 2023

Referred to the Subcommittee on Health.

Dec 14, 2023

Introduced in House

Dec 14, 2023

Referred to the Committee on Appropriations, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

What's happening now December 15, 2023

Referred to the Subcommittee on Health.

Bill text 1 version

Introduced in House Formatted Text PDF Formatted XML

Source documents hosted by congress.gov.

Committees of jurisdiction 3

Appropriations Committee
House of Representatives
Energy and Commerce Committee
House of Representatives
Health Subcommittee
House of Representatives · subcommittee of Energy and Commerce Committee